Vol 6 Issue 10

CELL AND GENE THERAPY INSIGHTS

November 2020 Issue

Vol 6 Issue 10

Download PDF

Featuring

Issue Spotlight: Cell therapy bioprocessing and analytics: today’s key tools and innovation requirements to meet future demand
Adherent culture systems 2020
Other articles
Webinars

SPOTLIGHT

Cell therapy bioprocessing and analytics: today’s key tools and innovation requirements to meet future demand
John Paul Tomtishen III
Guest Editor:
John Paul Tomtishen III, Director of Manufacturing, Technical Operations at Legend Biotech Co.

Foreword

Cell therapy bioprocessing and analytics: today’s key tools and innovation requirements to meet future demand

Cell therapy bioprocessing and analytics: today’s key tools and innovation requirements to meet future demand

John Paul Tomtishen III
1 December 2020
Read

Editorial

Process development: how to win the race in cell & gene therapy

Process development: how to win the race in cell & gene therapy

Ramin Baghirzade
4 November 2020
Read

Expert Insight

Measurement: the central nervous system of a quality manufacturing line for tissue engineering and regenerative medicine products

Measurement: the central nervous system of a quality manufacturing line for tissue engineering and regenerative medicine products

M Clare McCorry, R Robinson-Zeigler, R McFarland et al.
25 November 2020
Read
The role of flow cytometry in advanced therapy medicinal products

The role of flow cytometry in advanced therapy medicinal products

Theo Nastos, PhD
20 November 2020
Read
Limiting variability to achieve reproducibility in cell manufacturing

Limiting variability to achieve reproducibility in cell manufacturing

Anne Lamontagne, Andrew Fesnak
11 November 2020
Read

Innovator Insight

De-risking the final formulation, fill and finish step in cell therapy manufacturing: considerations for an automated solution

De-risking the final formulation, fill and finish step in cell therapy manufacturing: considerations for an automated solution

Dalip Sethi, Annie Cunningham
26 November 2020
Read

Expert Roundtable Video

Streamlining and optimizing viral vector bioprocess and analytical development

Streamlining and optimizing viral vector bioprocess and analytical development

J Tarnowski, N Kotsopoulou, K Patel et al.
22 December 2020
Watch

Expert Roundtable

Streamlining and optimizing viral vector bioprocess and analytical development

Streamlining and optimizing viral vector bioprocess and analytical development

J Tarnowski, N Kotsopoulou, K Patel et al.
19 January 2021
Read

Methodology Paper

A cell therapy media fill protocol for validation of aseptic processing of cord blood

A cell therapy media fill protocol for validation of aseptic processing of cord blood

F DeDino, K Vincent, D DiNello et al.
24 November 2020
Read

Interview

Addressing pain points in iPSC-derived cell therapy manufacture and scale-up

Addressing pain points in iPSC-derived cell therapy manufacture and scale-up

Bruno Marques, PhD
24 November 2020
Read
Industrializing allogeneic cell therapy bioprocessing: devising streamlined solutions to complex challenges

Industrializing allogeneic cell therapy bioprocessing: devising streamlined solutions to complex challenges

Lior Raviv
23 November 2020
Read
γδ T cell therapy: devising a manufacturing-friendly bioprocess

γδ T cell therapy: devising a manufacturing-friendly bioprocess

Dr Sean O’Farrell
17 November 2020
Read
Challenges & trends in stem cell-derived extracellular vesicle bioprocessing

Challenges & trends in stem cell-derived extracellular vesicle bioprocessing

Jorge L Escobar Ivirico
12 November 2020
Read

On Demand Webinar

Celyad Oncology’s case study: validation approach for accelerated mycoplasma testing

Celyad Oncology’s case study: validation approach for accelerated mycoplasma testing

Dr Sarah Snykers
7 January 2021
Read
Abbreviated in-house qualification of real time mycoplasma detection kit

Abbreviated in-house qualification of real time mycoplasma detection kit

Sowmya Viswanathan, PhD
7 January 2021
Read

Webinars on Demand: Expert Commentary

Celyad Oncology’s case study: validation approach for accelerated mycoplasma testing

Celyad Oncology’s case study: validation approach for accelerated mycoplasma testing

16 February 2021
Read

Vectors FOCUS

Adherent culture systems 2020

Editorial

Adherent systems for viral vector production

Adherent systems for viral vector production

Hemant Dhamne, PhD
18 December 2020
Read

Podcast

Viral vector manufacturing and transfection efficiency in the iCELLis® Bioreactor System

Viral vector manufacturing and transfection efficiency in the iCELLis® Bioreactor System

Rachel Leggmann, François Collard, Alengo Nyamay’Antu
17 December 2020
Listen

Interview

Viral vector manufacturing and transfection efficiency in the iCELLis® Bioreactor system

Viral vector manufacturing and transfection efficiency in the iCELLis® Bioreactor system

17 December 2020
Read

Journal articles

Editorial

How to standardize quality requirements of raw materials

How to standardize quality requirements of raw materials

Bernd Leistler
1 December 2020
Read

Commentary

Monoclonal antibodies to enable therapeutic tolerance to stem cell derived transplants?

Monoclonal antibodies to enable therapeutic tolerance to stem cell derived transplants?

Herman Waldmann
23 October 2020
Read

FastFacts

Managing donor collections during the COVID-19 pandemic

Managing donor collections during the COVID-19 pandemic

Joy Aho
4 November 2020
Read
GMP compliant residual PEIpro® test: one step closer to commercialization

GMP compliant residual PEIpro® test: one step closer to commercialization

Malik Hellal
3 November 2020
Read

Podcast

Developing a risk mitigation plan for gene therapy manufacturing - Podcast

Developing a risk mitigation plan for gene therapy manufacturing - Podcast

J Moscariello, C Davies, M Brewer et al.
9 November 2020
Listen

Interview

Advancing embryonic stem cell-based therapy in eye disease

Advancing embryonic stem cell-based therapy in eye disease

Jane Lebkowski
19 November 2020
Read
Developing a risk mitigation plan for gene therapy manufacturing

Developing a risk mitigation plan for gene therapy manufacturing

J Moscariello, C Davies, M Brewer et al.
9 November 2020
Read
Multi-modal cell and gene therapy facilities: futureproofing with flexible design

Multi-modal cell and gene therapy facilities: futureproofing with flexible design

Emily Thompson
6 November 2020
Read

Webinars